Characteristics and prevalence of clinical remission of rheumatoid arthritis in a nationwide study from Indonesia
ConclusionThe remission rate of Indonesian RA patients is 24.5%, and low disease activity is 18.5%. Methotrexate and leflunomide are the most frequent conventional DMARDs used. Delayed diagnosis, delayed treatment, and DMARD monotherapy contributed to the current low remission rate in Indonesia.
Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Bagus Putu Putra Suryana,
Rudy Hidayat,
Sumariyono Sarmidi,
Suryo Anggoro Kusumo Wibowo,
Laniyati Hamijoyo,
Andri Reza Rahmadi,
Blondina Marpaung,
Andi Raga Ginting,
Gede Kambayana,
Pande Ketut Kurniari,
Mahriani Sylvawani,
Najirman,
Nyoman S Tags: ORIGINAL ARTICLE Source Type: research
More News: Arthritis | Autoimmune Disease | Hydroxychloroquine | Indonesia Health | Methotrexate | Pain | Restasis | Rheumatoid Arthritis | Rheumatology | Study